CFCristiano Maria Francucci

Cristiano Maria Francucci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cristiano Maria Francucci has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 July 2011
      • Vol. 34, 1-2

    Primary hyperparathyroidism and skeleton. Foreword.

    by C M Francucci, E Ghigo, M Boscaro


    • 1 July 2011
      • Vol. 34, 13-7

    Role of calcium-sensing receptor in bone biology.

    by R Caudarella, F Vescini, A Buffa, E Rizzoli, L Ceccoli, C M Francucci

    Extracellular calcium concentration changes are recognized by Ca++ sensing receptor (CaR), a member of the G-protein-coupled receptor family. Recently, progress has been made in the understanding of CaR functional role in bone cells, notwithstanding a lack of detailed knowledge about the identity of the cation receptors. It is generally agreed that a high extracellular calcium induces osteoblast proliferation and osteoclastogenesis inhibition. Potential implications that may be considered include a role for CaR in osteogenesis, in serum calcium homeostasis regulation, and as a factor coupling bone formation to resorption in bone remodeling. The localization of CaR in bone cells provides further knowledge of the mechanisms operating in the bone remodeling model; in fact, increased calcium gradient in the site of bone resorption favors osteoblast precursors chemotaxis and inhibits osteoclasts through the increase of [Ca++]e. In vitro data indicate that CaR is a physiological regulator of bone cells, regulating the recruitment, differentiation and survival of osteoblasts and osteoclasts. This leads to the concept that the CaR present in bone cells may be targeted by agonists or antagonists to control bone cell metabolism and bone remodeling.


    • 1 January 2010
      • Vol. 33, 2-3

    Endocrinopathy-induced osteoporosis. Impact on health and economics of osteoporosis.

    by C M Francucci, E Ghigo, M Boscaro

  • Interregional survey – Abruzzo, Marche, Molise – on osteoporosis risk-factors and calculations on risks for fractures in five years with the BLACK-algorithm and in ten years with the SIOMMMS-algorithm

    by C.M. Francucci, M. Strappini, A. Di Felice, A. Spinelli, L. Ceccoli, G. Cenci, L. Del Forno, N. Franchi, N. Lapenna, G. Mancini, et al.

    • 1 January 2009
      • Vol. 32, 1

    Endocrinopathy-induced osteoporosis. Fourth National Meeting, Ancona, Italy, September 25-26, 2008.

    by C M Francucci, E Ghigo, M Boscaro

    • 1 January 2009
      • Vol. 32, 15-20

    Salt intake, hypertension, and osteoporosis.

    by R Caudarella, F Vescini, E Rizzoli, C M Francucci

    A high salt intake has been correlated with several pathological conditions such as hypertension, cardiovascular disease, renal calcium stones, and osteoporosis. Some of these diseases present a high prevalence in the elderly and common pathogenetic mechanisms are proposed for some of them. A high salt intake has been associated with hypertension as well as osteoporosis and one of the proposed pathogenetic mechanisms is an increased calcium excretion in urine. Urinary calcium loss induces a negative calcium balance that may predispose hypertensive subjects to developing greater bone loss. The gene which encodes for the thiazide- sensitive sodium-chloride cotransporter (NCCT) represents a possible link between hypertension and osteoporosis. Subjects heterozygous for an inactivating mutation of NCCT present a positive effect on bone density as shown by the significantly higher Z-scores at the lumbar spine and total femur. Recent clinical studies also support the benefit of ACE inhibitors in reducing fracture risk or improving bone metabolism. These data suggest that the renin-angiotensin system may be one of the several factors involved in bone metabolism. Hypertension, together with stroke, has been demonstrated to be a risk factor for osteoporosis. Although the risk associated with hypertension was limited in terms of relative risk, it may have a significant impact on the general population owing to the high prevalence of hypertension. The treatment of hypertension may thus be very useful in also giving protection against fractures.


    • 1 July 2008
      • Vol. 31, 1

    Foreword. Glucocorticoid-induced osteoporosis.

    by C M Francucci, E Ghigo, M Boscaro

  • Effect of natural early menopause on bone mineral density

    by C.M. Francucci, P. Romagni, A. Camilletti, P. Fiscaletti, L. Amoroso, G. Cenci, C. Morbidelli, M. Boscaro


    • 1 June 2007
      • Vol. 19, 11-4

    Morphometric dual-energy X-ray absorptiometry (MXA) for identification of vertebral fractures.

    by Cristiano Maria Francucci, Paola Romagni, Paola Fiscaletti, Renata Caudarella, Marco Boscaro

    Visual identification of vertebral fractures from spinal radiographs makes use of operator expertise in ruling out non-fracture deformities or normal variants. Morphometric X-ray absorptiometry (MXA) has recently been developed to assess vertebral deformity status quantitatively by dual energy X-ray absorptiometry (DXA). The reliability of MXA measurements depends on the precision of the technique, and this is influenced by system error, variability associated with morphometric analysis, and variability within study populations. This technique has proved to be useful in the identification and evaluation of osteoporotic vertebral deformities in both epidemiologic surveys and clinical trials. The major limitation of DXA vertebral assessment is the poor quality of images of thoracic vertebrae. We conclude that, used as a screening tool, this approach may help to identify vertebral fractures with a reduced radiation dose to the patient, and that technological improvements are necessary to improve image quality.

    • 1 January 2007
      • Vol. 30, 24-8

    Role of vitamin K on biochemical markers, bone mineral density, and fracture risk.

    by C M Francucci, S Rilli, P Fiscaletti, M Boscaro

    Osteoporosis is a multifactorial chronic disease that may become even more prevalent and more of a public health problem in the decades to come. Recent research has indicated that a number of macro- and micronutrients are involved in the development of bone health. In the past decade it became evident that vitamin K played a significant role in human health beyond its well-established function in blood clotting. In fact, among the proteins known or suspected to be involved in bone and vascular biology there are several members of the vitamin K dependent or gamma-carboxyglutamic acid protein family. Based on the current evidence from epidemiologic and intervention studies, there are insufficient data to recommend a routine supplementation of vitamin K for optimal bone health. New experimental and placebo-controlled studies in humans should clarify our understanding of the role vitamin K plays in improving bone health.